drugset / Trial / NCT06108830

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

NCT06108830

RandomizedParallel-groupQuadruple-blindPrevention

Summary

To explore the effects of esketamine combined with remimazolam on postoperative sleep disturbance and anxiety in surgical patients undergoing gastroenteroscopies

Timeline

Start
2023-12-01
Primary completion
2024-11-30
Completion
2024-12-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esketamine Other / unclassified 0.2 mg/kg
Comparator Remimazolam Small molecule 0.15 mg/kg

Indications